Digene To Pay $3.5M Over 13 Months In License Pact
Medical company Digene Corp. announced on Thursday that it will make nonrefundable sublicense payments totaling $3.5 million to Abbott Laboratories over the next 13 months for patents relating to human vitro...To view the full article, register now.
Already a subscriber? Click here to view full article